Bank Of Montreal Bio Xcel Therapeutics, Inc. Transaction History
Bank Of Montreal
- $191 Billion
- Q1 2024
A detailed history of Bank Of Montreal transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 42,108 shares of BTAI stock, worth $53,898. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,108
Previous 44,500
5.38%
Holding current value
$53,898
Previous $131,000
9.92%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BTAI
# of Institutions
77Shares Held
6.6MCall Options Held
85KPut Options Held
221K-
Black Rock Inc. New York, NY1.33MShares$1.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$1.41 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN579KShares$741,3290.0% of portfolio
-
State Street Corp Boston, MA465KShares$595,0820.0% of portfolio
-
Geode Capital Management, LLC Boston, MA458KShares$586,1370.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $35.9M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...